Zhongnan Medical Journal Press

Home Results

A total of 7 result was found. Results that relate to Pembrolizumab

One case of maculopapule induced by amoxicillin after pembrolizumab treatment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(1):95-98.
6982 times 3685 times

Jing GONG Xiao-Lin CHEN Xue-Li LIU Jun YANG

Pembrolizumab Amoxicillin Maculopapular drug eruption Immune activation
Details
Case report and literature analysis of hypothyroidism induced by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(2):227-232.
8557 times 3824 times

Fei-Long TAN Hong-Ying XIA Zhong-Juan WANG Li DING Li-Na YOU Li ZHOU Jian JIN

Pembrolizumab Immune checkpoint inhibitors Hypothyroidism Adverse drug reaction
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1311-1315.
6788 times 1487 times

Jin-Jin ZOU Ji-Liang ZHANG Ni LI Ding-Yi LIU

Pembrolizumab Lung squamous cell carcinoma Severe immune-related ulcerative colitis Adverse drug reactions
Details
A case of severe immune liver injury caused by pembrolizumab and rechallenge

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):212-217.
6915 times 1704 times

LIU Min YANG Limei YIN Yue ZHAO Bingqing

Pembrolizumab Immune related liver injury Rechallenge of immunotherapy
Details
Cost-utility analysis of pembrolizumab combined with chemotherapy for advanced malignant pleural mesothelioma

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1107-1114.
7891 times 1412 times

HU Yunjia ZOU Keqing HOU Yanhong

Pembrolizumab Chemotherapy Advanced malignant pleural mesothelioma Partitioned survival model Cost-utility analysis Pharmacoeconomic evaluation
Details
One case of anaphylaxis caused by pembrolizumab injection

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1196-1200.
6844 times 1192 times

HUANG Shuzhen CHEN Xiongjian

Pembrolizumab Anaphylaxis Adverse drug reaction
Details
A case of toxic epidermal necrolysis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1314-1319.
8485 times 1395 times

HUANG Lingling LI Xialin HUANG Guangyao LUO Peng WANG Weimin WANG Junping

Pembrolizumab Lung cancer Toxic epidermal necrolysis Adverse drug reaction
Details